Skip to content

Clinical trials

Completed Phase 2 Medulloblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Medulloblastoma Phase: Phase 2 Status: Completed Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20021
20032
20062
20073
20082
20091
20103
20133
20151
20175
20181
20191
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)13
Children's Oncology Group3
Herbert Irving Comprehensive Cancer Center2
Memorial Sloan Kettering Cancer Center2
Pfizer2
Sue O'Dorisio2
Ann & Robert H Lurie Children's Hospital of Chicago1
Barbara Ann Karmanos Cancer Institute1
Celgene1
Children's Cancer and Leukaemia Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Medulloblastoma45
Central Nervous System Neoplasms26
Neuroblastoma17
Astrocytoma16
Ependymoma15
Glioma14
Brain Neoplasms12
Oligodendroglioma11
Osteosarcoma11
Sarcoma11

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.